Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Infusion of Cold vs Room Temperature Ringer's Lactate in Healthy Volunteers
NCT06622499Phase 1Completed
- Sponsor
- Esbjerg Hospital - University Hospital of Southern Denmark
- Start
- Nov 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lactated ringer's solution in hemodynamic instability (2 arms), sponsored by Esbjerg Hospital - University Hospital of Southern Denmark. Primary endpoint: Increase in Mean Arterial Pressure at 30 months. Started Nov 2023; status: completed.
02
Drugs
lactated ringer's solution
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT06622499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06622499.